William Geist Power - 01 Feb 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Feb 2024, 18:36:03 UTC
Prior SEC filing
09 Nov 2023
Next SEC filing
19 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed

Key filing fact

William Geist Power filed Form 4 for BIO-TECHNE Corp (TECH) on 05 Feb 2024.

Key facts

  • This page summarizes William Geist Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 1 reported transaction and 10 derivative rows are listed below.
  • Accepted by SEC: 05 Feb 2024, 18:36.

Change

  • Previous filing in this sequence was filed on 09 Nov 2023.
  • Current net transaction value: -$76,148.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Tax liability

Transaction value
$76,148
Shares
-1,111
Change %
-13%
Price
$68.54
Shares after
7,759
Date
01 Feb 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,360
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,360
Exercise price
Footnotes
F2, F3
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,936
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,936
Exercise price
$100.39
Footnotes
F3
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,912
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,912
Exercise price
$100.39
Footnotes
F4
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,140
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,140
Exercise price
Footnotes
F2, F5
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
22,200
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,200
Exercise price
$94.52
Footnotes
F5
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
29,600
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
29,600
Exercise price
$94.52
Footnotes
F6
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,074
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,074
Exercise price
Footnotes
F2, F7
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24,424
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,424
Exercise price
$84.61
Footnotes
F7
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,059
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,059
Exercise price
$84.61
Footnotes
F8
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,823
Date
01 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,823
Exercise price
Footnotes
F2, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Includes 3,320 shares of restricted stock units for which the risk of forfeiture will lapse on 2/1/2025.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F3

Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F4

Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 3,976 shares vest on each of 2/1/2025 and 2/1/2026.

Footnote F5

Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F6

Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

Footnote F7

Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F8

Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.

Footnote F9

9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .